A multicentre trial of recombinant growth hormone and low dose oestrogen in Turner syndrome: near final height analysis
BACKGROUND—Turner syndrome accounts for 15-20% of childhood usage of growth hormone (GH) in the UK but final height benefit remains uncertain. The most effective strategy for oestrogen replacement is also unclear. METHODS—Fifty eight girls who, at start of treatment, were of mean age 9.1 years and p...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2001
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1718629/ https://ncbi.nlm.nih.gov/pubmed/11124794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/adc.84.1.76 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|